about
Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization Algorithm.Fully human monoclonal antibody inhibitors of the neonatal fc receptor reduce circulating IgG in non-human primates.IgG Conformer's Binding to Amyloidogenic Aggregates.Role of biologics in intractable urticaria.Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases.Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.Biological roles of glycans.Predictors of extubation outcomes following myasthenic crisis.FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment.Role of intravenous immunoglobulin in the treatment of Kawasaki disease.[Immunomodulatory therapy of autoimmune diseases : Quo vadis?].
P2860
Q33795940-0B5A9F4B-4020-451E-9258-27B0AF1439B3Q35531873-6E937DE5-B52A-4EF0-A9B3-996FBBF95E5EQ35772596-2B24C908-0272-4766-9E88-F48CDA3D29B2Q38450662-1B811FD0-36AA-4868-B409-79DA4D177E17Q38635412-19797CA7-AB25-422C-ACD7-551D0A9DB67EQ38900642-57B51581-3448-4610-ACB1-3B030894BD36Q38936714-58359D60-854B-4DC1-938F-75D8A7230603Q39179335-573515EE-7B24-4E68-8694-E7CBA1A9F016Q40050324-5A767246-91E8-4B7A-96D2-ADB363DE051CQ47445453-9074F0EA-B4BC-4289-B180-8A1E595F38D7Q50071875-2201A20C-19A0-4F7B-BE0D-5C126F17EE9EQ52852647-69BC9F28-5873-45FD-9AB4-696FB9E0288D
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Mechanisms of immune regulation by IVIG.
@en
type
label
Mechanisms of immune regulation by IVIG.
@en
prefLabel
Mechanisms of immune regulation by IVIG.
@en
P1476
Mechanisms of immune regulation by IVIG.
@en
P2093
Mark Ballow
P304
P356
10.1097/ACI.0000000000000116
P577
2014-12-01T00:00:00Z